AMZN vs. LLY: Amazon.com vs. Eli Lilly Stock Comparison
How do Amazon.com (AMZN) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Amazon.com (AMZN) is classified in the Consumer Discretionary sector (Consumer Discretionary Distribution & Retail), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AMZN | LLY |
|---|---|---|
| Name | Amazon.com, Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Consumer Discretionary | Health Care |
| GICS Industry Group | Consumer Discretionary Distribution & Retail | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Broadline Retail | Pharmaceuticals |
| GICS Sub-Industry | Broadline Retail | Pharmaceuticals |
| Market Capitalization | 2,960.63 billion USD | 1,057.35 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | May 15, 1997 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AMZN | LLY |
|---|---|---|
| Total Return (1Y) | 23.01% | 86.33% |
| Total Return (3Y, Annualized) | 24.50% | 38.69% |
| Total Return (5Y, Annualized) | 10.42% | 36.38% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Amazon.com (AMZN) has an aggressive beta of 1.45, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.50 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | AMZN | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 34.38% | 35.74% |
| Beta (5Y) | 1.45 | 0.50 |
| Max Drawdown (5Y) | -55.73% | -34.48% |
| Avg. Volume (3M) | 50.02M | 3.06M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AMZN | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 0.55 | 2.30 |
| Sortino Ratio (1Y) | 0.91 | 4.03 |
Profitability
ROE (TTM)
Eli Lilly (LLY) at 102.29% sits in the top ROE quartile, while Amazon.com (AMZN) at 30.56% is closer to the peer norm — stronger capital efficiency for LLY.
AMZN
Consumer Discretionary Distribution & Retail industry group
30.56%
- Max
- 63.82%
- Q3
- 32.02%
- AMZN
- 30.56%
- Median
- 14.10%
- Q1
- 5.61%
- Min
- -29.94%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
102.29%
- LLY
- 102.29%
- Max
- 102.29%
- Q3
- 2.88%
- Median
- -33.17%
- Q1
- -64.41%
- Min
- -157.61%
Net Margin (TTM)
Eli Lilly (LLY) at 33.53% keeps the most of each sales dollar — above its industry’s net margin range — and Amazon.com (AMZN) at 17.44% also retains a top-quartile share.
AMZN
Consumer Discretionary Distribution & Retail industry group
17.44%
- Max
- 20.45%
- AMZN
- 17.44%
- Q3
- 8.90%
- Median
- 3.34%
- Q1
- 0.82%
- Min
- -9.03%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
33.53%
- LLY
- 33.53%
- Max
- 11.21%
- Q3
- 2.65%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -13.58%
Operating Margin (TTM)
Both Amazon.com (AMZN) at 13.69% and Eli Lilly (LLY) at 54.22% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AMZN
Consumer Discretionary Distribution & Retail industry group
13.69%
- Max
- 21.57%
- AMZN
- 13.69%
- Q3
- 11.98%
- Median
- 5.18%
- Q1
- 2.33%
- Min
- -8.71%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
54.22%
- Max
- 94.41%
- LLY
- 54.22%
- Q3
- 8.92%
- Median
- 0.00%
- Q1
- -119.39%
- Min
- -309.54%
Profitability Metrics
| Metric | AMZN | LLY |
|---|---|---|
| ROE (TTM) | 30.56% | 102.29% |
| ROA (TTM) | 6.59% | 20.36% |
| Net Margin (TTM) | 17.44% | 33.53% |
| Operating Margin (TTM) | 13.69% | 54.22% |
| Gross Margin (TTM) | 50.77% | 83.40% |
Growth
Revenue Growth
Amazon.com (AMZN) at 12.38% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for AMZN.
EPS Growth
Both Amazon.com (AMZN) at 29.66% and Eli Lilly (LLY) at 95.99% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | AMZN | LLY |
|---|---|---|
| Revenue Growth (YoY) | 12.38% | 44.70% |
| Revenue Growth (3Y CAGR) | 11.73% | 31.69% |
| EPS Growth (YoY) | 29.66% | 95.99% |
| EPS Growth (3Y CAGR) | -- | 51.71% |
Financial Strength
Current Ratio (MRQ)
Amazon.com (AMZN) at 1.03 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.36 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
AMZN
Consumer Discretionary Distribution & Retail industry group
1.03
- Max
- 2.71
- Q3
- 1.86
- Median
- 1.36
- AMZN
- 1.03
- Q1
- 1.03
- Min
- 0.49
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.36
- Max
- 26.16
- Q3
- 12.25
- Median
- 5.88
- Q1
- 2.81
- LLY
- 1.36
- Min
- 0.55
Debt / Equity (MRQ)
Amazon.com (AMZN) at 0.46 keeps leverage in the lower quartile, while Eli Lilly (LLY) at 1.62 sits in the higher-leverage quartile.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.46
- Max
- 3.49
- Q3
- 1.86
- Median
- 1.10
- Q1
- 0.72
- AMZN
- 0.46
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.62
- Max
- 1.64
- LLY
- 1.62
- Q3
- 0.68
- Median
- 0.16
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AMZN | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.03 | 1.36 |
| Debt / Equity (MRQ) | 0.46 | 1.62 |
| Net Debt / EBITDA | 0.76 | 1.10 |
Dividends
Dividend Yield (TTM)
Amazon.com (AMZN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a yield of 0.54%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 5.71%
- Q3
- 2.49%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.54%
- LLY
- 0.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Amazon.com (AMZN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a payout of 21.69%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 78.51%
- Q3
- 31.95%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.69%
- LLY
- 21.69%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AMZN | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.54% |
| Dividend Payout Ratio (TTM) | 0.00% | 21.69% |
Valuation
P/E Ratio (TTM)
Both Amazon.com (AMZN) at 21.89 and Eli Lilly (LLY) at 40.00 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AMZN
Consumer Discretionary Distribution & Retail industry group
21.89
- Max
- 61.33
- Q3
- 32.81
- AMZN
- 21.89
- Median
- 20.74
- Q1
- 12.63
- Min
- 1.17
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.00
- Max
- 84.14
- Q3
- 43.16
- LLY
- 40.00
- Median
- 28.60
- Q1
- 15.80
- Min
- 2.32
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.27 is priced about in line with its industry on P/S ratio, while Amazon.com (AMZN) at 3.82 sits in the pricier quartile — AMZN costs more per dollar of sales.
AMZN
Consumer Discretionary Distribution & Retail industry group
3.82
- AMZN
- 3.82
- Max
- 3.82
- Q3
- 1.81
- Median
- 0.82
- Q1
- 0.30
- Min
- 0.03
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.27
- Max
- 70.39
- Q3
- 30.57
- LLY
- 13.27
- Median
- 7.62
- Q1
- 3.50
- Min
- 0.01
P/B Ratio (MRQ)
Amazon.com (AMZN) at 5.37 sits near its industry’s typical P/B ratio, while Eli Lilly (LLY) at 33.96 prices above its benchmark range — LLY looks rich relative to book.
AMZN
Consumer Discretionary Distribution & Retail industry group
5.37
- Max
- 11.78
- Q3
- 5.54
- AMZN
- 5.37
- Median
- 2.24
- Q1
- 1.20
- Min
- -4.94
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
33.96
- LLY
- 33.96
- Max
- 17.22
- Q3
- 8.05
- Median
- 3.87
- Q1
- 1.75
- Min
- -7.69
Valuation Metrics
| Metric | AMZN | LLY |
|---|---|---|
| P/E Ratio (TTM) | 21.89 | 40.00 |
| P/S Ratio (TTM) | 3.82 | 13.27 |
| P/B Ratio (MRQ) | 5.37 | 33.96 |
| Free Cash Flow Yield (TTM) | 0.11% | 1.05% |